![Second dose of AstraZeneca COVID-19 vaccine: FAQs about blood clots, safety, risks and symptoms – Brighter World Second dose of AstraZeneca COVID-19 vaccine: FAQs about blood clots, safety, risks and symptoms – Brighter World](https://brighterworld.mcmaster.ca/wp-content/uploads/sites/2/2021/05/Conversation-Astra-Zeneca-1.jpeg)
Second dose of AstraZeneca COVID-19 vaccine: FAQs about blood clots, safety, risks and symptoms – Brighter World
ERHA Trinidad & Tobago - The Eastern Regional Health Authority will commence its roll-out of the AstraZeneca COVID-19 Vaccine Second Dose on Monday 7th June, 2021. See details below. | Facebook
![Comparing the longer-term effectiveness of a single dose of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines across the age spectrum - eClinicalMedicine Comparing the longer-term effectiveness of a single dose of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines across the age spectrum - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1bba1167-47f6-431c-bdce-0faee0f92314/gr1_lrg.jpg)
Comparing the longer-term effectiveness of a single dose of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines across the age spectrum - eClinicalMedicine
![Com-COV2 study supports flexible second dose options following Pfizer or Oxford/AstraZeneca jabs | University of Oxford Com-COV2 study supports flexible second dose options following Pfizer or Oxford/AstraZeneca jabs | University of Oxford](https://www.ox.ac.uk/sites/files/oxford/styles/ow_medium_feature/s3/field/field_image_main/Com-Cov%20news_1.jpg?itok=WA--UD2P)
Com-COV2 study supports flexible second dose options following Pfizer or Oxford/AstraZeneca jabs | University of Oxford
![Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c0547203-d7c7-4471-bd9b-1440f4613981/gr1_lrg.jpg)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
![Government to fund COVID-19 clinical trial using different vaccines for first and second doses - The Pharmaceutical Journal Government to fund COVID-19 clinical trial using different vaccines for first and second doses - The Pharmaceutical Journal](https://pharmaceutical-journal.com/wp-content/uploads/2021/02/Covid-19-Pfizer-AstraZeneca-vaccines-SPL-21-927x617.jpg)
Government to fund COVID-19 clinical trial using different vaccines for first and second doses - The Pharmaceutical Journal
![I got AstraZeneca for my first dose. Which should I get for my second?' A COVID vaccination guide - Healthy Debate I got AstraZeneca for my first dose. Which should I get for my second?' A COVID vaccination guide - Healthy Debate](https://healthydebate.ca/wp-content/uploads/2021/06/are_you_fully_vaccinated-scaled-e1624310241681.jpg)